According to scPharmaceuticals's latest financial reports the company's current EPS (TTM) is -1,30 โฌ. In 2022 the company made an earnings per share (EPS) of -1,27 โฌ a decrease over its 2021 EPS that were of -1,01 โฌ.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -1,26 โฌ | -0.54% |
2022 | -1,27 โฌ | 26.21% |
2021 | -1,01 โฌ | -21.97% |
2020 | -1,29 โฌ | -25.42% |
2019 | -1,73 โฌ | 12.03% |
2018 | -1,54 โฌ | -25.95% |
2017 | -2,08 โฌ |